Winton Group’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-19,356
| Closed | -$812K | – | 1068 |
|
|
2023
Q1 | $812K | Buy |
19,356
+3,848
| +25% | +$161K | 0.05% | 514 |
|
|
2022
Q4 | $591K | Buy |
15,508
+370
| +2% | +$14.1K | 0.04% | 581 |
|
|
2022
Q3 | $593K | Sell |
15,138
-1,821
| -11% | -$71.3K | 0.04% | 590 |
|
|
2022
Q2 | $548K | Buy |
16,959
+3,287
| +24% | +$106K | 0.03% | 668 |
|
|
2022
Q1 | $453K | Buy |
13,672
+2,246
| +20% | +$74.4K | 0.02% | 710 |
|
|
2021
Q4 | $486K | Sell |
11,426
-26,922
| -70% | -$1.15M | 0.03% | 684 |
|
|
2021
Q3 | $1.7M | Buy |
38,348
+19,108
| +99% | +$847K | 0.1% | 256 |
|
|
2021
Q2 | $1.09M | Buy |
19,240
+10,408
| +118% | +$591K | 0.06% | 481 |
|
|
2021
Q1 | $661K | Sell |
8,832
-1,959
| -18% | -$147K | 0.04% | 716 |
|
|
2020
Q4 | $934K | Sell |
10,791
-39,886
| -79% | -$3.45M | 0.07% | 445 |
|
|
2020
Q3 | $3.1M | Sell |
50,677
-5,734
| -10% | -$350K | 0.1% | 314 |
|
|
2020
Q2 | $2.35M | Buy |
+56,411
| New | +$2.35M | 0.06% | 575 |
|
|
2020
Q1 | – | Sell |
-18,659
| Closed | -$1.35M | – | 1522 |
|
|
2019
Q4 | $1.35M | Buy |
18,659
+15,740
| +539% | +$1.14M | 0.02% | 945 |
|
|
2019
Q3 | $410K | Buy |
+2,919
| New | +$410K | ﹤0.01% | 1155 |
|
|
2019
Q1 | – | Sell |
-2,680
| Closed | -$257K | – | 1168 |
|
|
2018
Q4 | $257K | Sell |
2,680
-811
| -23% | -$77.8K | 0.01% | 717 |
|
|
2018
Q3 | $493K | Buy |
3,491
+689
| +25% | +$97.3K | 0.01% | 632 |
|
|
2018
Q2 | $439K | Sell |
2,802
-778
| -22% | -$122K | 0.01% | 674 |
|
|
2018
Q1 | $577K | Buy |
+3,580
| New | +$577K | 0.02% | 706 |
|